TrialMolecular therapy : the journal of the American Society of Gene Therapy2012

Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vector.

Dawn E Bowles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.